Français📈 See the interactive version (live chart) →
| Metric | Value | What it means |
|---|---|---|
| P/E (price / earnings) | 252.8 | The higher, the more growth the market expects. |
| Forward P/E | 69.0 | On next year's expected earnings. Lower than current P/E = rising earnings. |
| PEG (P/E ÷ growth) | — | Below 1 = cheap given growth; above 2 = expensive. |
| Net margin | 5% | Share of revenue that ends up as profit. |
| Revenue growth | 12% | Pace of revenue growth. |
| Price-to-book | 4.9 | Price relative to book value. |
| Market cap | $10.3 B | Total market value of the company. |
| Dividend yield | — | No dividend currently. |
| Year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2022 | $802 M | $186 M | 23% |
| 2023 | $639 M | $42 M | 7% |
| 2024 | $634 M | $-26 M | -4% |
| 2025 | $738 M | $49 M | 7% |
📊 Open the interactive Repligen page (charts, live news) →
Repligen has a P/E of 252.8 (forward P/E 69.0) and a PEG of —. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.
Repligen's net margin is about 5% — the share of revenue that ends up as net profit.
Latest known revenue: $738 M for net income of $49 M. The year-by-year breakdown is in the income statement above.
Repligen (RGEN) has a market cap of about $10.3 B.
No, Repligen does not currently pay a dividend (it reinvests earnings).
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.